Australia markets open in 8 hours 18 minutes

Sorrento Therapeutics, Inc. (SRNE)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.5995+0.0895 (+5.93%)
As of 11:42AM EDT. Market open.
Currency in USD
Earnings estimateCurrent qtr. (Mar 2022)Next qtr. (Jun 2022)Current year (2022)Next year (2023)
No. of analysts1111
Avg. Estimate-0.16-0.25-0.948.42
Low estimate-0.16-0.25-0.948.42
High estimate-0.16-0.25-0.948.42
Year ago EPS0.01-0.57-1.45-0.94
Revenue estimateCurrent qtr. (Mar 2022)Next qtr. (Jun 2022)Current year (2022)Next year (2023)
No. of analysts1111
Avg. Estimate18.39M18.75M75.78M5.1B
Low estimate14.54M18.75M75.78M5.1B
High estimate14.54M18.75M75.78M5.1B
Year ago sales14.26M10.13M52.9M75.78M
Sales growth (year/est)29.00%85.10%43.20%6,636.60%
Earnings history30/03/202129/06/202129/09/202130/12/2021
Est. EPS0.38-0.2-0.23-0.29
Actual EPS0.01-0.57-0.4-0.47
Difference-0.37-0.37-0.17-0.18
Surprise %-97.40%-185.00%-73.90%-62.10%
EPS trendCurrent qtr. (Mar 2022)Next qtr. (Jun 2022)Current year (2022)Next year (2023)
Current estimate-0.16-0.25-0.948.42
7 days ago-0.16-0.13-0.948.42
30 days ago-0.16-0.13-1.249.48
60 days ago-0.16-0.13-0.839.48
90 days ago-0.16-0.13-0.5710.04
EPS revisionsCurrent qtr. (Mar 2022)Next qtr. (Jun 2022)Current year (2022)Next year (2023)
Up last 7 daysN/AN/A1N/A
Up last 30 daysN/A11N/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/A1
Growth estimatesSRNEIndustrySector(s)S&P 500
Current qtr.-1,700.00%N/AN/AN/A
Next qtr.56.10%N/AN/AN/A
Current year35.20%N/AN/AN/A
Next year995.70%N/AN/AN/A
Next 5 years (per annum)37.00%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A